Quest Partners LLC Has $26,000 Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Quest Partners LLC cut its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 89.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,190 shares of the pharmacy operator’s stock after selling 19,182 shares during the period. Quest Partners LLC’s holdings in Walgreens Boots Alliance were worth $26,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Syon Capital LLC acquired a new stake in Walgreens Boots Alliance in the 4th quarter valued at about $333,000. EP Wealth Advisors LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $297,000. Corient Private Wealth LLC increased its holdings in shares of Walgreens Boots Alliance by 38.9% in the fourth quarter. Corient Private Wealth LLC now owns 280,545 shares of the pharmacy operator’s stock valued at $7,325,000 after purchasing an additional 78,523 shares in the last quarter. Sanders Morris Harris LLC lifted its holdings in Walgreens Boots Alliance by 373.3% during the 1st quarter. Sanders Morris Harris LLC now owns 112,398 shares of the pharmacy operator’s stock worth $2,438,000 after buying an additional 88,650 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. boosted its position in Walgreens Boots Alliance by 15.3% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 301,910 shares of the pharmacy operator’s stock valued at $7,883,000 after buying an additional 40,095 shares during the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Down 3.0 %

Shares of Walgreens Boots Alliance stock opened at $8.71 on Friday. Walgreens Boots Alliance, Inc. has a 1 year low of $8.46 and a 1 year high of $27.05. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31. The company has a market capitalization of $7.52 billion, a P/E ratio of -1.29, a price-to-earnings-growth ratio of 1.02 and a beta of 0.70. The business has a 50-day moving average of $10.29 and a two-hundred day moving average of $14.77.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company had revenue of $36.40 billion during the quarter, compared to the consensus estimate of $35.94 billion. During the same period in the previous year, the firm posted $1.00 EPS. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 2.86 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.48%. Walgreens Boots Alliance’s payout ratio is presently -14.84%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on WBA shares. Evercore ISI cut their price target on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a research note on Friday, June 28th. UBS Group reduced their target price on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 3rd. Royal Bank of Canada dropped their target price on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 2nd. Bank of America reduced their price target on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research report on Wednesday, September 4th. Finally, Truist Financial dropped their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday, June 28th. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and an average target price of $14.73.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.